BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23126225)

  • 1. Thermal ablation in renal cell carcinoma: what affects renal function?
    Park SY; Park BK; Kim CK
    Int J Hyperthermia; 2012; 28(8):729-34. PubMed ID: 23126225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local thermal ablation of renal cell carcinoma.
    Feng B; Liang P
    Eur J Radiol; 2012 Mar; 81(3):437-40. PubMed ID: 21239130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small renal tumors: natural history, observation strategies and emerging modalities of energy based tumor ablation.
    Derweesh IH; Novick AC
    Can J Urol; 2003 Jun; 10(3):1871-9. PubMed ID: 12892573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal tumor ablation.
    Georgiades C; Rodriguez R
    Tech Vasc Interv Radiol; 2013 Dec; 16(4):230-8. PubMed ID: 24238378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer.
    Heuer R; Gill IS; Guazzoni G; Kirkali Z; Marberger M; Richie JP; de la Rosette JJ
    Eur Urol; 2010 Feb; 57(2):223-32. PubMed ID: 19853989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermal ablation of renal cell carcinoma: triage, treatment, and follow-up.
    Thumar AB; Trabulsi EJ; Lallas CD; Brown DB
    J Vasc Interv Radiol; 2010 Aug; 21(8 Suppl):S233-41. PubMed ID: 20656233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel methods for renal tissue ablation.
    Olweny EO; Cadeddu JA
    Curr Opin Urol; 2012 Sep; 22(5):379-84. PubMed ID: 22706069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage of local recurrence after primary thermal ablation for small renal masses.
    Nguyen CT; Campbell SC
    Expert Rev Anticancer Ther; 2008 Dec; 8(12):1899-905. PubMed ID: 19046110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiofrequency ablation of small renal cortical tumours in healthy adults: renal function preservation and intermediate oncological outcome.
    Stern JM; Gupta A; Raman JD; Cost N; Lucas S; Lotan Y; Raj GV; Cadeddu JA
    BJU Int; 2009 Sep; 104(6):786-9. PubMed ID: 19426196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous radiofrequency ablation: minimally invasive therapy for renal tumors.
    Ahrar K; Wallace MJ; Matin SF
    Expert Rev Anticancer Ther; 2006 Dec; 6(12):1735-44. PubMed ID: 17181487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Under-grading of <4 cm renal masses on renal biopsy.
    Harris CR; Whitson JM; Meng MV
    BJU Int; 2012 Sep; 110(6):794-7. PubMed ID: 22404857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale for total nephrectomy for suspected renal cell carcinoma.
    Marsh CL; Lange PH
    Semin Urol Oncol; 1995 Nov; 13(4):273-80. PubMed ID: 8595551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephron-sparing surgery for renal cell carcinoma in the solitary kidney.
    Berdjis N; Hakenberg OW; Novotny V; Manseck A; Oehlschläger S; Wirth MP
    Scand J Urol Nephrol; 2007; 41(1):10-3. PubMed ID: 17366096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation of small renal cell carcinomas using multitined expandable electrodes: preliminary experience.
    Clark TW; Malkowicz B; Stavropoulos SW; Sanchez R; Soulen MC; Itkin M; Patel A; Mondschein JI; Wein AJ
    J Vasc Interv Radiol; 2006 Mar; 17(3):513-9. PubMed ID: 16567676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors.
    Gervais DA; McGovern FJ; Arellano RS; McDougal WS; Mueller PR
    AJR Am J Roentgenol; 2005 Jul; 185(1):64-71. PubMed ID: 15972400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of margin in nephron sparing surgery for renal cell carcinoma of 4 cm or less.
    Li QL; Guan HW; Wang FP; Jiang T; Wu HC; Song XS
    Chin Med J (Engl); 2008 Sep; 121(17):1662-5. PubMed ID: 19024095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current management of small renal masses.
    Trinh QD; Saad F; Lattouf JB
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):180-5. PubMed ID: 19553818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incomplete thermal ablation stimulates proliferation of residual renal carcinoma cells in a translational murine model.
    Kroeze SG; van Melick HH; Nijkamp MW; Kruse FK; Kruijssen LW; van Diest PJ; Bosch JL; Jans JJ
    BJU Int; 2012 Sep; 110(6 Pt B):E281-6. PubMed ID: 22612555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial).
    Wendler JJ; Porsch M; Nitschke S; Köllermann J; Siedentopf S; Pech M; Fischbach F; Ricke J; Schostak M; Liehr UB
    Contemp Clin Trials; 2015 Jul; 43():10-9. PubMed ID: 25962890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal Ablation Techniques: State of the Art.
    Higgins LJ; Hong K
    AJR Am J Roentgenol; 2015 Oct; 205(4):735-41. PubMed ID: 26204112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.